266 related articles for article (PubMed ID: 26199983)
1. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
[TBL] [Abstract][Full Text] [Related]
2. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
[TBL] [Abstract][Full Text] [Related]
3. Improving selection criteria for lung cancer screening. The potential role of emphysema.
Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
[TBL] [Abstract][Full Text] [Related]
4. Overdiagnosis in low-dose computed tomography screening for lung cancer.
Patz EF; Pinsky P; Gatsonis C; Sicks JD; Kramer BS; Tammemägi MC; Chiles C; Black WC; Aberle DR;
JAMA Intern Med; 2014 Feb; 174(2):269-74. PubMed ID: 24322569
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
6. Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.
Oken MM; Hocking WG; Kvale PA; Andriole GL; Buys SS; Church TR; Crawford ED; Fouad MN; Isaacs C; Reding DJ; Weissfeld JL; Yokochi LA; O'Brien B; Ragard LR; Rathmell JM; Riley TL; Wright P; Caparaso N; Hu P; Izmirlian G; Pinsky PF; Prorok PC; Kramer BS; Miller AB; Gohagan JK; Berg CD;
JAMA; 2011 Nov; 306(17):1865-73. PubMed ID: 22031728
[TBL] [Abstract][Full Text] [Related]
7. Lung cancer incidence and mortality in National Lung Screening Trial participants who underwent low-dose CT prevalence screening: a retrospective cohort analysis of a randomised, multicentre, diagnostic screening trial.
Patz EF; Greco E; Gatsonis C; Pinsky P; Kramer BS; Aberle DR
Lancet Oncol; 2016 May; 17(5):590-9. PubMed ID: 27009070
[TBL] [Abstract][Full Text] [Related]
8. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
[TBL] [Abstract][Full Text] [Related]
9. Results of the Randomized Danish Lung Cancer Screening Trial with Focus on High-Risk Profiling.
Wille MM; Dirksen A; Ashraf H; Saghir Z; Bach KS; Brodersen J; Clementsen PF; Hansen H; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thomsen LH; Tønnesen P; Pedersen JH
Am J Respir Crit Care Med; 2016 Mar; 193(5):542-51. PubMed ID: 26485620
[TBL] [Abstract][Full Text] [Related]
10. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
[TBL] [Abstract][Full Text] [Related]
11. CT screening for lung cancer brings forward early disease. The randomised Danish Lung Cancer Screening Trial: status after five annual screening rounds with low-dose CT.
Saghir Z; Dirksen A; Ashraf H; Bach KS; Brodersen J; Clementsen PF; Døssing M; Hansen H; Kofoed KF; Larsen KR; Mortensen J; Rasmussen JF; Seersholm N; Skov BG; Thorsen H; Tønnesen P; Pedersen JH
Thorax; 2012 Apr; 67(4):296-301. PubMed ID: 22286927
[TBL] [Abstract][Full Text] [Related]
12. Should we be screening for COPD? - looking through the lens of lung cancer screening.
Young RP; Scott RJ
Expert Rev Respir Med; 2023; 17(9):753-771. PubMed ID: 37728077
[TBL] [Abstract][Full Text] [Related]
13. CT screening for lung cancer: alternative definitions of positive test result based on the national lung screening trial and international early lung cancer action program databases.
Yip R; Henschke CI; Yankelevitz DF; Smith JP
Radiology; 2014 Nov; 273(2):591-6. PubMed ID: 24955929
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study.
Gagnat AA; Gulsvik A; Bakke P; Gjerdevik M
Clin Respir J; 2019 Feb; 13(2):114-119. PubMed ID: 30597746
[TBL] [Abstract][Full Text] [Related]
15. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
[TBL] [Abstract][Full Text] [Related]
16. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
[TBL] [Abstract][Full Text] [Related]
17. Applying the National Lung Screening Trial eligibility criteria to the US population: what percent of the population and of incident lung cancers would be covered?
Pinsky PF; Berg CD
J Med Screen; 2012 Sep; 19(3):154-6. PubMed ID: 23060474
[TBL] [Abstract][Full Text] [Related]
18. Extrapulmonary Findings and Malignancies in Participants Screened With Chest CT in the National Lung Screening Trial.
Nguyen XV; Davies L; Eastwood JD; Hoang JK
J Am Coll Radiol; 2017 Mar; 14(3):324-330. PubMed ID: 28259326
[TBL] [Abstract][Full Text] [Related]
19. Baseline characteristics of participants in the randomized national lung screening trial.
; Aberle DR; Adams AM; Berg CD; Clapp JD; Clingan KL; Gareen IF; Lynch DA; Marcus PM; Pinsky PF
J Natl Cancer Inst; 2010 Dec; 102(23):1771-9. PubMed ID: 21119104
[TBL] [Abstract][Full Text] [Related]
20. Indolent, Potentially Inconsequential Lung Cancers in the Pittsburgh Lung Screening Study.
Thalanayar PM; Altintas N; Weissfeld JL; Fuhrman CR; Wilson DO
Ann Am Thorac Soc; 2015 Aug; 12(8):1193-6. PubMed ID: 26107281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
